The information and services provided by the Center for Advocacy for Cancer of the Testes International (CACTI) are for informational purposes only. The information and services are not intended to be substitutes for professional medical advice, diagnosis or treatment. If you are ill, or suspect that you are ill, seek professional medical attention immediately. CACTI does not recommend or endorse any specific physicians, treatments, procedures or products, even though they may be mentioned on this site.
Imerman Angels was created on the belief that no one should have to face cancer alone and without the necessary support. At 26 years old, Jonny Imerman was diagnosed with testicular cancer and began his fight against the disease. Throughout his experience, Jonny was lucky enough to have loving support from his family and friends but had never met anyone his age who was a cancer survivor. He wanted to talk to someone just like him, someone who truly understood, and was intimately familiar with his experience. In 2003, Jonny founded Imerman Angels.
Through their unique matching process, Imerman Angels partners anyone seeking cancer support – a “Mentor Angel”. A Mentor Angel is a cancer survivor or caregiver who is the same age, same gender, and most importantly who has faced the same type of cancer. The service is absolutely free and helps anyone touched by any type of cancer, at any cancer stage level, at any age, living anywhere in the world. These one-on-one relationships give a cancer fighter or caregiver the chance to ask personal questions and get support from someone who has been there before.
Instapeer is a peer-based app, designed by an organization called Stupid Cancer, which joins cancer patients, survivors and caregivers to lend support to each other through their social network.
Stupid Cancer, a 501(c)3 nonprofit organization, is the largest charity that comprehensively addresses young adult cancer through advocacy, research, support, outreach, awareness, mobile health and social media.
Their innovative, award-winning and evidence-based programs and services serve as a global bullhorn to propel the young adult cancer movement forward.
CaringBridge is the first and most widely used social networking site focused on communicating with loved ones during a serious health journey. Starting with one website, the inaugural CaringBridge website allowed people to easily get updates and offer support and encouragement.
Word spread, and others began to request their own CaringBridge websites. In 2002, CaringBridge became a 501(c)(3) nonprofit organization, providing support when it’s needed most, and their reach has grown. Since 1997, more than half a million CaringBridge websites have been created.
One in nine people in the U.S. have used CaringBridge to rally support for a loved one, and their reach extends to 236 countries and territories around the world.
Fertile Action is a non-profit cancer charity working to ensure fertile women touched by the disease can become mothers. Specifically they educate and advocate for patients and physicians, and they provide support and financial aid, including fertility scholarships. Alice Crisci founded Fertile Action as the My Vision Foundation in 2008 a few weeks after she was diagnosed with breast cancer at 31-years-old. Struck by the limited resources available for young women with cancer, and fueled by her personal experience funding her fertility preservation on her American Express card, Crisci vowed to protect the vision women touched by cancer have of their future.
Critical Mass, The Young Adult Cancer Alliance, is made up of non-profits, medical professionals, medical institutions, patient advocacy groups, government agencies, clinicians, researchers and dedicated individuals all united by a shared passion to improve the lives of young adults with cancer.
Together, they strive to be the unifying voice of the young adult cancer community as they work side-by-side to raise awareness, build the evidence base, and change the way young adults with cancer are cared for and treated.